Overall Status

Completed (8)

Unknown status (7)

Recruiting (6)

Active, not recruiting (2)

Not yet recruiting (2)

Terminated (2)

Withdrawn (1)

Phase

n/a (14)

phase 1 (2)

phase 1/phase 2 (2)

phase 2 (2)

early phase 1 (1)

Collaborator

Avex LLC (1)

Fondazione Italiana Vascolare (1)

Massachusetts General Hospital (1)

NAMSA (1)

NHS Greater Glasgow and Clyde Board HQ (1)

Prairie Education and Research Cooperative (1)

Ryerson University (1)

Society for Vascular Surgery Patient Safety Organization (1)

The Medical Device Epidemiology Network (MDEpiNet) (1)

Study Documents

Intervention Type

device (16)

drug (4)

procedure (4)

biological (2)

dietary supplement (2)

other (2)

Funder Type

Other (17)

Industry (11)

Study Type

Interventional (21)

Observational (4)

Observational [Patient Registry] (3)

pad

Showing 26 - 28 of 28

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

PAD Trial in Chongqing (Percutaneous transluminal angioplasty)

Unknown status

Percutaneous transluminal angioplasty

Chongqing, China

The third hospital affiliated to the Third Military Medical Univ

Apr 21, 2016

PAD Trial in Worldwide (Cotavance Paclitaxel Coated Balloon, Standard balloon angioplasty)

Terminated

Cotavance Paclitaxel Coated Balloon
Standard balloon angioplasty

Graz, Austria
+5 more

Jun 5, 2015

PAD, Claudication Trial in Ann Arbor, Philadelphia (MultiGeneAngio)

Active, not recruiting

PAD
Claudication

MultiGeneAngio

Ann Arbor, Michigan
+1 more

Mar 4, 2015